Margin expansion is real, but organic growth leans on rupee weakness
Q1 revenue growth of 17.7% is heavily inflated by forex; constant-currency growth of 6.6% matches peer average, not beat it. EBIT margin expanded 330 bps YoY and sits on track to the 15% FY27 target, but Q2 will test the company's cost discipline as wage increases and other one-off benefits reverse.
₹15,712 Cr
+17.7% YoY
6.6% YoY
peer-parity growth
14.4%
+330 bps YoY, +60 bps QoQ
$1.078B
+33% YoY · 3rd consecutive >$1B
$167M
+94% YoY
15%
reiterated, achievable path
The forex lens: where the 17.7% came from
A headline revenue growth of 17.7% year-on-year in INR looks strong, but peel away the currency effect and the story shifts. The constant-currency growth was 6.6%—matching peer average, not beating it. The company's own opening remarks led with the organic number ($1.66B USD, 6.6% CC YoY), yet the press and market fixated on the rupee-reported 17.7%. That gap—11 percentage points—is pure forex tailwind from INR weakness. Useful for reported metrics, not a sign of organic outperformance.
Where profits really came from
EBIT margin sits at 14.4%, an expansion of 330 basis points year-on-year and 60 basis points quarter-on-quarter. That's the genuine story of Q1. Management attributed the move to three forces: volume growth from large deals ramping, Project Fortius productivity savings (fixed-price engagement tools and automation), and SG&A consolidation. Against this came headwinds—Comviva seasonality in the Comms vertical, European auto dilution, visa/travel costs—yet the net was still a solid +330 bps. This margin expansion is credible and organic.
But the path to the FY27 target of 15% faces pressures. Q2 will see a wage increase effective (phased, starting Q2). Management will also face productivity headwinds from AI infrastructure CapEx. The company remains confident in hitting 15% but acknowledged it won't be a walk—'we will certainly have some productivity pressures from an AI perspective, and we still have to deliver the 15% margin. So we're not taking that for granted and losing our discipline on large deals and on profitable growth.'
What management claimed, and what holds up
Strongest revenue growth since transformation start
6.6% constant-currency YoY is peer-parity, not exceptional. Reported 17.7% is INR-inflated by 11.1 pp from forex.
Overstated
Margin expansion for 11 consecutive quarters
EBIT 14.4% in Q1, up 330 bps YoY from ~11.1% prior year. Trajectory visible and supported.
Supported
Billion-plus deal wins delivered ($1.078B TCV)
$1.078B in Q1, up 33% YoY. Third consecutive quarter >$1B. Broad-based across verticals.
Supported
Every vertical delivered YoY growth
Comms +1.3%, BFSI +8.1%, Manufacturing +17.2%, Retail +8.6%, Healthcare +7.2%. All positive.
Supported
Operating margin of 15% achievable for FY27
Q1 14.4% with credible path (Project Fortius, volume ramps). Q2 headwinds (wage increase, AI CapEx) but mgmt disciplined.
Supported, but Q2 test ahead
Above-peer-average growth this year
Q1 delivery: 6.6% CC growth claimed as strongest; actual = peer-parity. Guidance vague; no quantified peer benchmark offered.
Unproven
What changed on this call
Three shifts from prior guidance: (1) Margin momentum reaffirmed. The 330-bps YoY expansion and 60-bps QoQ move give management confidence the 15% FY27 target is achievable, despite wage and AI CapEx headwinds. (2) Growth narrative softened. Management reiterated 'above-peer-average' growth but dodged specific FY27 revenue CAGR targets, citing macro volatility. The call was peppered with 'enormous volatility' language. Analysts pressed hard (Sudhir, Ankur, others), and mgmt held firm: 'it would be foolhardy of me to give you any specific numbers.' (3) Large deal execution stays binary. CEO Mohit Joshi was blunt: 'For large deals specifically, it's quite a binary outcome, it's a zero or one, and our ability to forecast beyond let's say a quarter or two, is quite limited.' This honesty is refreshing but underscores execution risk.
Near-term headwinds also came into focus. European auto's acceleration in Q1 (an aerospace offset) was a one-off; that benefit reverses in Q2 with an estimated 1–1.3% revenue drag. DSO improved to 84 days (down 5 days QoQ) from accelerated payments and FX AR gains—this won't repeat. Management is being transparent about these: no heroic claims, just steady execution.
The bull case vs. the bear case
EBIT margin 14.4%, up 330 bps YoY, on track to 15% target with credible path
Deal wins $1.078B, third consecutive >$1B quarter; broad-based across verticals and geographies
All five verticals delivered YoY growth; manufacturing +17.2%, BFSI +8.1%, healthcare +7.2%, retail +8.6%, comms +1.3%
Free cash flow $167M (+94% YoY); operational excellence and collection discipline evident
ROCE 28.3% (+450 bps YoY); enhanced profitability and capital discipline
Added 7 new $50M+ revenue clients YoY; deepening relationships in strategic accounts
Reported revenue growth 17.7% is 63% driven by forex; organic constant-currency growth 6.6% = peer-parity, not beat
European auto acceleration was a one-off Q1 benefit (~1–1.3%); reverses Q2
DSO improvement to 84 days benefited from FX AR gains and accelerated payments; mgmt flagged normalization ahead
Large deal execution is binary; mgmt admits forecast visibility only 1–2 quarters
Q2 wage increase effective (phased), plus AI CapEx productivity pressures, yet guidance on margin path vague
FY27 growth guidance vague ('above peer average' with no quantified peer benchmark or CAGR target); deflection on specifics
Comms vertical only +1.3% YoY despite two large deals in pipeline; cloud pass-through and Comviva seasonality explanations given but signal execution caution
FII ownership declining steadily (24.2% in Q3 FY25 to 18.6% in Q4 FY26) despite strong results; institutional vote of no-confidence
Large deal execution (binary outcomes, limited forecast visibility)
HighThird consecutive >$1B TCV is impressive, but mgmt admits 'ability to forecast beyond 1–2 quarters is quite limited.' Ramp velocity and revenue contribution are unknowable beyond 1–2 quarters. European auto acceleration showed variability. If the billion-quarter cadence stops or large deals ramp slower, 'above-peer' growth claim evaporates.
Organic growth sustainability (6.6% CC = peer-parity, not outperformance)
HighReported 17.7% is forex-inflated by 11 pp. If rupee strengthens or USD weakens, headline growth disappoints. Q2 European auto reversal (~1–1.3%) will further pressure growth. Management's narrative of 'strongest growth since transformation' relies on INR-reported number—organic story is peer-level.
Margin sustainability amid cost inflation (wage increase Q2, AI CapEx pressures)
MediumQ1 14.4% was helped by seasonality tailwinds and one-offs (auto acceleration, DSO gains). Q2 wage increase (effective phased) and AI infrastructure CapEx will pressure gross margins. Management claims 15% achievable but won't relax pricing discipline—leaves limited lever for hitting target.
Macro volatility and client demand uncertainty
MediumManagement repeatedly invoked 'enormous volatility.' Examples cited: clients questioning multi-year outsourcing contracts, AI ROI skepticism, requests for in-house alternatives. If macro deteriorates further or clients defer transformation programs, deal pipeline velocity suffers.
Vertical concentration and segment volatility
MediumTMT vertical declined 1.7% QoQ (demand volatility). Comms only +1.3% YoY despite large deal ramps pending (execution caution). Auto sector (subset of manufacturing +17.2%) faces EV/US/Europe weakness. Customer concentration metrics undisclosed beyond $50M+ client count.
How the Street is positioned (price, ownership, technicals)
Price action held firm. The day-1 pop was +4.14%; by day 3 it was +4.37%. The initial rally didn't fade—a sign the market's confidence in Q1 execution was genuine. Management delivered on margin expansion, deal wins, and execution. That conviction held.
But technicals are stretched. At ₹1,576.3, the stock is 15% below its all-time high of ₹1,854. Against that, it sits above the 20-day, 50-day, and 200-day moving averages (SMA20 ₹1,461.68, SMA50 ₹1,454.61, SMA200 ₹1,487.56). The RSI is 82.8—deeply overbought—suggesting the 3-day rally has run far and a pullback is possible. The 52-week range (₹1,304–₹1,854) shows the stock near cycle highs, not lows.
Institutional flows are a red flag. FII ownership has declined from 24.20% in Q3 FY25 to 18.59% in Q4 FY26—a drop of 5.6 percentage points over five quarters. DII ownership held steady at 37.33%. Promoter stake unchanged at 34.97%. Foreign investors are trimming despite strong Q1 results. This suggests FII concerns about: (a) organic growth reliance on forex, (b) large deal execution risk beyond 1–2 quarters, or (c) valuation after the pop. The technical rally and the institutional selling are pulling in opposite directions—a sign the market is skeptical on sustainability.
1 · Q2 and H2 large deal ramp-up materialize
Will the $1B+ deals won over past 12 months flow to revenue on schedule? Mgmt says forecast visibility is 1–2 quarters only. If Q2 large deal revenue disappoints (e.g., delays, lower-than-expected contribution), the growth narrative breaks. This is the binary outcome mgmt flagged.
2 · Can management hit 15% EBIT despite Q2 wage increase and AI CapEx?
Q1 hit 14.4% with one-off benefits (auto acceleration, DSO gains). Q2 loses those. Wage increase effective Q2 will pressure cost structure. Can fixed-price productivity and SG&A consolidation offset? This is the execution test.
3 · Does FII trimming continue or stabilize?
Foreign ownership down 560 bps over five quarters. If selling continues into the post-results rally, it signals institutional skepticism on the growth narrative. If it stabilizes, it means the print was enough to restore confidence. Ownership trends are a tell of conviction.
4 · Rupee strength/weakness impact on FY27 reported growth
Organic 6.6% CC is peer-parity. If rupee strengthens significantly, reported growth will look worse. Currency tailwinds are exhausting (rupee already weak). Monitor whether mgmt can drive CC growth above 6.6% without forex help.
This is steady execution, not a step-change. EBIT margin expansion is real (330 bps YoY, on track to 15%). Deal momentum is genuine (three consecutive >$1B quarters). But the growth story is not an outperformance tale—it's peer-parity organic growth masked by rupee weakness. Management is disciplined on pricing and honest about risks (macro volatility, large deal execution binary, Q2 headwinds), which is refreshing. What's missing is specificity: no FY27 revenue CAGR target, no quantified peer benchmark, no 2–3 year forward guidance.
The market's day-3 rally held (+4.37%), but RSI is overbought (82.8) and FII is trimming (−560 bps over five quarters). The stock is 15% off ATH but still priced on optimistic assumptions about large deal ramp-up velocity and margin sustainability. Q2 will be the test: wage increases, auto reversal, and DSO normalization are concrete headwinds. If management navigates those and the large deals flow to revenue on schedule, the confidence is warranted. If not, the post-results pop may fade.
Track one number from here: the organic constant-currency revenue growth rate. If Q2 CC growth stays above 6% despite the European auto reversal and large deal lumpiness, the 'above-peer-average' claim has legs. If it falls below 5%, management has a growth problem that margins alone can't fix. For now, the verdict is: good execution, credible margin path, unproven growth narrative, and elevated Q2 execution risk.
Informational and educational content only. Not investment advice.